Journal
Journal of Medical Economics
Publication Date
1-1-2023
Volume
26
Issue
1
First Page
488
Last Page
493
Document Type
Open Access Publication
DOI
10.1080/13696998.2023.2192588
Rights and Permissions
Gebrehiwet P, Meng L, Rudnicki SA, Sarocco P, Wei J, Wolff AA, Butzner M, Chiò A, Andrews JA, Genge A, Hughes DA, Jackson CE, Lechtzin N, Miller TM, Shefner JM. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS. J Med Econ. 2023 Jan-Dec;26(1):488-493. doi: 10.1080/13696998.2023.2192588. © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
Recommended Citation
Gebrehiwet, Paulos; Meng, Lisa; Rudnicki, Stacy A; Sarocco, Phil; Wei, Jenny; Wolff, Andrew A; Butzner, Michael; Chiò, Adriano; Andrews, Jinsy A; Genge, Angela; Hughes, Dyfrig A; Jackson, Carlayne E; Lechtzin, Noah; Miller, Timothy M; and Shefner, Jeremy M, "Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS." Journal of Medical Economics. 26, 1. 488 - 493. (2023).
https://digitalcommons.wustl.edu/oa_4/1644
Department
ICTS (Institute of Clinical and Translational Sciences)
